10x Genomics
(NASDAQ) TXG
10x Genomics Financials at a Glance
Market Cap
$2.35B
Revenue (TTM)
$642.82M
Net Income (TTM)
$43.54M
EPS (TTM)
$-0.35
P/E Ratio
-52.60
Dividend
$0.00
Beta (Volatility)
1.99 (High)
Dividend
$0.00
Beta (Volatility)
1.99 (High)
Price
$18.38
Volume
54,476
Open
$18.37
Price
$18.38
Volume
54,476
Open
$18.37
Previous Close
$18.38
Daily Range
$18.10 - $18.64
52-Week Range
$6.78 - $23.56
Dividend
$0.00
Beta (Volatility)
1.99 (High)
Price
$18.38
Volume
54,476
Open
$18.37
Previous Close
$18.38
Daily Range
$18.10 - $18.64
52-Week Range
$6.78 - $23.56
TXG News
TXG: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 10x Genomics
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
1,178
CEO
Serge Saxonov, PhD
Website
www.10xgenomics.comHeadquarters
Pleasanton, CA 94588-3260, US
TXG Financials
Key Financial Metrics (TTM)
Gross Margin
69%
Operating Margin
-9%
Net Income Margin
-7%
Return on Equity
-6%
Return on Capital
-7%
Return on Assets
-4%
Earnings Yield
-1.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.35B
Shares Outstanding
127.75M
Volume
54.48K
Short Interest
0.00%
Avg. Volume
2.54M
Financials (TTM)
Gross Profit
$443.88M
Operating Income
$110.89M
EBITDA
$110.89M
Operating Cash Flow
$136.05M
Capital Expenditure
$5.93M
Free Cash Flow
$130.12M
Cash & ST Invst.
$523.41M
Total Debt
$157.74M
10x Genomics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$166.03M
+0.6%
Gross Profit
$113.05M
+1.9%
Gross Margin
68.09%
N/A
Market Cap
$2.35B
N/A
Market Cap/Employee
$1.80M
N/A
Employees
1,306
N/A
Net Income
$16.25M
+66.9%
EBITDA
$19.54M
+48.3%
Quarterly Fundamentals
Net Cash
$365.67M
+17.7%
Accounts Receivable
$82.49M
-6.1%
Inventory
$56.34M
-32.2%
Long Term Debt
$146.75M
+100.1%
Short Term Debt
$10.98M
+18.3%
Return on Assets
-4.18%
N/A
Return on Invested Capital
-6.87%
N/A
Free Cash Flow
$39.00M
+512.1%
Operating Cash Flow
$40.78M
+704.3%